← Back to all signals
RESEARCH PAPER ANALYSIS

Tumour dimension is a prognostic factor in thymic epithelial tumours: An update analysis from the ESTS thymic database: Tumour dimension in thymic tumours.

AI interpretation is pending for this paper.

Open original publication →
PMID40220716
JournalLung cancer (Amsterdam, Netherlands)
Publication Date2025-04-08
Ingested2026-08-02 12:04 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

OBJECTIVE: The 9thTNM proposal for thymic epithelial tumours (TETs) introduced size as category in stage I, confirming tumour infiltration type as descriptor for the other stages. Aim of this study is to evaluate the role of tumour size in TETs considering different possible cut-offs also among different subgroups. MATERIAL AND METHODS: Clinical and pathological data of patients from ESTS thymic database who underwent surgery for TETs from1/2000 to 12/2022 were reviewed and analysed. Patients clinical data, tumour characteristics, size and organs infiltration were collected and correlated to overall survival (OS), Disease free Survival (DFS) and Cancer specific Survival (CSS) using Kaplan Meier curves. The log-rank test was used to assess differences between subgroups. A multivariable model was built using Cox-regression analysis including clinical relevant variables resulting significant at univariable (p-value < 0.05). RESULTS: The final analysis was conducted on 2146 patients. Most patients presented tumours size >5 cm(59 %)and without surrounding structures infiltrations (51.3 %). During FUP, a recurrence occurred in 235 (11%) patients, 199 (9.3%) died, 38 due to tumour progression. Multivariable confirmed as independent negative prognostic factors age (p < 0.001), carcinoma/NETT histology (p < 0.001),TETs size >5 cm (p < 0.001, HR 2.16; 95 %CI 1.32-3.50), and infiltration (p = 0.04) for OS; advanced TNM STAGE 9th edition (p < 0.001) and carcinoma/NETT (p = 0.001) for DFS; infiltration presence (p < 0.001) and carcinoma/NETT (p < 0.001) for CSS. Significant differences in OS, DFS and CSS were present considering size cut-off 5 cm (p < 0.001, p < 0.001 and p = 0.001, respectively), while using 3 cm cut-off only DFS (p < 0.001) and CSS (p = 0.001) resulted statistically significant. Significant differences in OS, DFS and CSS were present considering surrounding organ infiltration in TETs ≤ 5 cm (p = 0.004, p < 0.001 and p = 0.001) and in TETs > 5 cm (p = 0.024, p < 0.001 and p < 0.001). CONCLUSIONS: Tumour size resulted a significant prognosticator in TETs, and its associations with infiltration permits to identify different prognostic groups.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Atypical Case of Presumed Bartonella henselae Osteomyelitis in a Child with Cat-Scratch Disease Mimicking a Malignant Bone Tumor. Children (Basel, Switzerland) 56.2 2 Gait and Functional Movement Quality Improvements Following an Individualized Exercise Program in Pediatric Hemato-Oncological Patients. Children (Basel, Switzerland) 57.0 3 Scaling Adolescent Immunity: Multi-Age Cohort Human Papillomavirus (HPV) Vaccination Campaigns in West Africa-Evidence from Côte d'Ivoire, Ghana, Liberia, and Sierra Leone. Vaccines 59.9 4 CNN Sample-Size Effects Across Biomedical Datasets: A Reliability Pattern in Overfitting, Ranking, and Monotonicity. Bioengineering (Basel, Switzerland) 57.5 5 Psychological Assessment of Parenting Stress and Emotional Support: A Moderated Mediation Model of Psychological Distress and Well-Being Among Childbearing-Age Women with Thyroid Cancer. Behavioral sciences (Basel, Switzerland) 41.5 6 Infected Urachal Cyst Presenting as a Huge Abdominal Abscess in an Elderly: A Case Report. Cureus 47.5 7 Metastatic Retroperitoneal Rhabdomyosarcoma in a Child: A Case Report Highlighting the Role of Imaging in Diagnosis, Staging, and Follow-Up. Cureus 65.5 8 Consumer Risk Characterisation of Potentially Toxic Elements in European Seabass (Dicentrarchus labrax) Marketed in Hungary. Toxics 40.5 9 Dynamic Metabolic Parameters and Deauville Score on 18F-FDG PET/CT for Prognostic Assessment in Pediatric Burkitt Lymphoma. Children (Basel, Switzerland) 72.3 10 Clinical and Dermoscopic Determinants of Surgical Decision-Making in Skin Cancer Screening: A Retrospective Analysis. Medicina (Kaunas, Lithuania) 65.0 11 The Oral and Nasal Gateway Microbiomes: Salivaomics and Systemic Health at the Airway-Digestive Interface. Microorganisms 58.0 12 Knowledge and Perceptions of Human Papillomavirus Infection and Vaccination Among Adolescents in French Rural Family Homes: A Mixed-Methods Study. Vaccines 68.7 13 Study of Telomere Length Kinetics and Telomerase Reverse Transcriptase Gene Polymorphism in Children Undergoing Allogeneic Haematopoietic Stem Cell Transplantation. Genes 58.7 14 Familial florid cemento-osseous dysplasia in two young sisters: case report and literature review. British dental journal 52.3 15 Laparoscopic Wilms Tumor Nephrectomy and Lymph Node Sampling: Oncotechnical Considerations. Journal of Indian Association of Pediatric Surgeons 63.4 16 Xanthogranulomatous Orchitis Masquerading as Chronic Epididymo-orchitis in a Paediatric Patient. Journal of Indian Association of Pediatric Surgeons 58.0 17 Dermatofibrosarcoma Protuberans of the Scalp in a 15-year-old Boy: A Rare Pediatric Surgical Challenge. Journal of Indian Association of Pediatric Surgeons 43.0 18 An Analysis of Multilevel Barriers to Human Papillomavirus Vaccination Uptake Among Rural U.S. Adolescents. Vaccines 58.0 19 Health-Related Quality of Life in Children with Acute Leukaemia and Central Nervous System Tumours: Current Evidence and Future Directions. Children (Basel, Switzerland) 61.6 20 Clinical Characteristics and Antimicrobial Resistance Profiles of Pediatric Enterococcal Infections: A Comparison Between Enterococcus faecium and Enterococcus faecalis. Pathogens (Basel, Switzerland) 69.4 21 Precision Medicine in Pediatric Nephrology: From Shared Clinical Phenotypes to Genotype-Guided Diagnosis and Management. Genes 68.44 22 Adolescent Helicobacter pylori Screening for Gastric Cancer Prevention: Current Evidence and Future Perspectives. Children (Basel, Switzerland) 61.4 23 Novel Homozygous LAMC3 Frameshift Variant Associated with Confluent Leukoencephalopathy and Low-Grade Tectal Glioneuronal Tumor: Expanding the Phenotypic Spectrum with Bioinformatic Characterization. Life (Basel, Switzerland) 56.0 24 Venous Thromboembolism in Neonates, Children, and Adolescents: A Comprehensive Narrative Review of Risk Factors, Diagnosis, Treatment, and Prevention. Medicina (Kaunas, Lithuania) 62.94 25 Multiple High-Risk HPV Infections and Opportunistic HPV Prevalence Among Women Aged 18-25 Years with NILM, ASC-US, or LSIL Cytology: A 2024 Cross-Sectional Study. Pathogens (Basel, Switzerland) 64.5 26 Special Issue "Pediatric Diseases: From Molecular Mechanisms to Novel Therapeutic Strategies". International journal of molecular sciences 54.09 27 The Osteosarcoma Tumor Microenvironment: From Cellular Interactions to Advanced Preclinical Models. Cancers 55.5 28 Fear of Cancer Progression as a Psychological Component of Cancer Rehabilitation in Men Treated for Reproductive System Malignancies: A Multi-Regional Cross-Sectional Study in Kazakhstan. Healthcare (Basel, Switzerland) 63.8 29 Pediatric DOCK8 Deficiency Beyond Infections and Atopy: An Immunoactinopathy with Immune Dysregulation and Multisystem Involvement. Children (Basel, Switzerland) 62.1 30 The Emerging Role of Ferroptosis in Pediatric Cancer Biology and Therapy. International journal of molecular sciences 74.0 31 Aprepitant, a Neurokinin-1 Receptor Antagonist, as a Disruptive Drug for the Treatment of Pediatric Cancer. Journal of clinical medicine 72.9 32 Osteosarcoma Across the Age Spectrum: Why Outcomes Diverge and Trials Must Adapt. Journal of clinical medicine 62.0
PATIENT-FRIENDLY SUMMARY

Tumour dimension is a prognostic factor in thymic epithelial tumours: An update analysis from the ESTS thymic database: Tumour dimension in thymic tumours.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic